{
    "organizations": [],
    "uuid": "d8632d68880390496787d7e352808c1eba4af58a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/eiger-biopharma-study/eiger-biopharma-abandons-blood-pressure-drug-after-failed-study-idUSL3N1PB471",
    "ord_in_thread": 0,
    "title": "Eiger BioPharma abandons blood pressure drug after failed study",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 16 (Reuters) - Eiger BioPharmaceuticals Inc said on Tuesday it would stop testing its drug ubenimex for the treatment of pulmonary arterial hypertension, a type of high blood pressure, after the drug failed to meet the main goal in a mid-stage study.\nThe company said it would continue testing the drug for lymphedema, a blockage of fluid causing swelling in the arms and legs. (Reporting by Manas Mishra in Bengaluru; Editing by Martina Dâ€˜Couto)\n ",
    "published": "2018-01-16T21:13:00.000+02:00",
    "crawled": "2018-01-17T19:55:14.013+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "eiger",
        "biopharmaceuticals",
        "inc",
        "said",
        "tuesday",
        "would",
        "stop",
        "testing",
        "drug",
        "ubenimex",
        "treatment",
        "pulmonary",
        "arterial",
        "hypertension",
        "type",
        "high",
        "blood",
        "pressure",
        "drug",
        "failed",
        "meet",
        "main",
        "goal",
        "study",
        "company",
        "said",
        "would",
        "continue",
        "testing",
        "drug",
        "lymphedema",
        "blockage",
        "fluid",
        "causing",
        "swelling",
        "arm",
        "leg",
        "reporting",
        "manas",
        "mishra",
        "bengaluru",
        "editing",
        "martina",
        "couto"
    ]
}